Ovidio Muñiz-Grijalvo Selected Research

Ovidio Muñiz-Grijalvo Research Topics

10	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2024 - 01/2019
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 07/2018
4	Atherosclerosis 03/2024 - 12/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 07/2018
3	Inflammation (Inflammations) 01/2023 - 12/2019
3	Pancreatitis 05/2021 - 09/2018
3	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2018
3	Hypertriglyceridemia 12/2020 - 09/2018
3	Costello Syndrome 12/2020 - 09/2018
3	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 12/2020 - 09/2018
2	Atherosclerotic Plaque (Atheroma) 01/2024 - 01/2023
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2021
1	Acute Coronary Syndrome 01/2023
1	Abdominal Pain (Pain, Abdominal) 05/2021
1	Heart Valve Diseases (Valvular Heart Disease) 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Arteriosclerosis 11/2018
1	Pathologic Constriction (Stenosis) 07/2018
1	Ectopic ACTH Syndrome 04/2015
1	Carcinoid Tumor (Carcinoid) 04/2015

6	LDL CholesterolIBA 01/2023 - 07/2018
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 11/2019
4	LipidsIBA 03/2024 - 11/2018
4	oxidized low density lipoproteinIBA 07/2021 - 01/2019
3	alirocumabIBA 01/2024 - 07/2021
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2019
3	Lipoprotein(a)IBA 01/2022 - 01/2021
3	CalciumIBA 12/2021 - 07/2018
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 05/2021 - 09/2018
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 01/2022
2	CholesterolIBA 01/2023 - 12/2020
2	Proprotein Convertase 9IBA 01/2023 - 01/2023
2	ChylomicronsIBA 05/2021 - 12/2020
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Apolipoprotein C-IIIIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Ezetimibe (Zetia)FDA Link 01/2023
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	evolocumabIBA 07/2021
1	PCSK9 InhibitorsIBA 07/2021
1	Apolipoproteins B (ApoB)IBA 12/2020
1	ApolipoproteinsIBA 12/2020
1	VLDL LipoproteinsIBA 12/2020
1	Monoclonal AntibodiesIBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 11/2018
1	Apolipoprotein A-VIBA 11/2018
1	Apolipoprotein C-II (ApoC2)IBA 11/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2015

5	Therapeutics 03/2024 - 09/2018
2	Aftercare (After-Treatment) 01/2024 - 01/2023
2	Mediterranean Diet 01/2021 - 12/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 09/2018